Skip to main content

CORRECTION article

Front. Neurosci., 31 March 2023
Sec. Neurodevelopment
Volume 17 - 2023 | https://doi.org/10.3389/fnins.2023.1189154
This article is part of the Research Topic Innovative approaches and therapeutic perspectives for early-onset neurodevelopmental disorders: from bench to bedside View all 15 articles

Corrigendum: Prader-Willi syndrome: Symptoms and topiramate response in light of genetics

This article is a correction to:

  1. Prader–Willi syndrome: Symptoms and topiramate response in light of genetics

    1. Read original article
\nCcile Louveau Cécile Louveau1*Mimi-Caterina TurtuliciMimi-Caterina Turtulici1Angle Consoli,Angèle Consoli2,3Christine PoitouChristine Poitou4Muriel CoupayeMuriel Coupaye4Marie-Odile Krebs,Marie-Odile Krebs1,5Boris Chaumette,,Boris Chaumette1,5,6Anton Iftimovici, Anton Iftimovici1,5*
  • 1Centre de Référence pour les Maladies Rares à expression Psychiatrique, GHU Paris Psychiatrie et Neurosciences, Paris, France
  • 2Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France
  • 3GRC-15, Dimensional Approach of Child and Adolescent Psychotic Episodes, Faculté de Médecine, Sorbonne Université, Paris, France
  • 4Nutrition Department, Rare Diseases Center of Reference “Prader–Willi Syndrome and Obesity With Eating Disorders” (PRADORT), Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, INSERM, Nutriomics, Sorbonne Université, Paris, France
  • 5Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France
  • 6Department of Psychiatry, McGill University, Montréal, QC, Canada

A corrigendum on
Prader-Willi syndrome: Symptoms and topiramate response in light of genetics

by Louveau, C., Turtulici, M.-C., Consoli, A., Poitou, C., Coupaye, M., Krebs, M.-O., Chaumette, B., and Iftimovici, A. (2023). Front. Neurosci. 17:1126970. doi: 10.3389/fnins.2023.1126970

In the published article, an author name was incorrectly written as Turtuluci. The correct spelling is Turtulici.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Prader–Willi, topiramate, treatment, genetics, deletion, disomy, personalized medicine

Citation: Louveau C, Turtulici M-C, Consoli A, Poitou C, Coupaye M, Krebs M-O, Chaumette B and Iftimovici A (2023) Corrigendum: Prader-Willi syndrome: Symptoms and topiramate response in light of genetics. Front. Neurosci. 17:1189154. doi: 10.3389/fnins.2023.1189154

Received: 18 March 2023; Accepted: 20 March 2023;
Published: 31 March 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Louveau, Turtulici, Consoli, Poitou, Coupaye, Krebs, Chaumette and Iftimovici. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Cécile Louveau, cecile.louveau@ghu-paris.fr; Anton Iftimovici, anton.iftimovici@inserm.fr

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.